Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DK235586Aexternal-prioritypatent/DK235586D0/da
Priority claimed from DK580586Aexternal-prioritypatent/DK580586D0/da
Priority claimed from PCT/DK1987/000057external-prioritypatent/WO1987007292A1/en
Application filed by Novo Industri AsfiledCriticalNovo Industri As
Priority to DK012188ApriorityCriticalpatent/DK159663C/da
Publication of DK12188D0publicationCriticalpatent/DK12188D0/da
Publication of DK12188ApublicationCriticalpatent/DK12188A/da
Publication of DK159663BpublicationCriticalpatent/DK159663B/da
Application grantedgrantedCritical
Publication of DK159663CpublicationCriticalpatent/DK159663C/da
14,17alfa-ethano- og ethanooestratriener, fremgangsmaate forfremstilling av disse forbindelser, saavel som anvendelse av dem for fremstilling av legemidler.
Fremgangsmaate til fremstilling av cefemer, oksacefemer ogkarbacefemer og 3-sulfonyloksy-substituerte cefemer, oksacefemer og karbacefemer som utgangsprodukt ved fremgangsmaaten.
Fremgangsmaate for fremstilling av 1-aminoalkyl-3-oksosubstituert-4-aryl-1,3,4,5-tetrahydro-2h-1,3-benzodiazepin-2-on, og deres anvendelse som medikamenter.